College News

Muhammad Furqan, M.D., professor of hematology-oncology at the University of Oklahoma College of Medicine and Associate Director of Clinical Research at OU Health Stephenson Cancer Center, is leading a national clinical trial evaluating whether immunotherapy can improve outcomes for patients with stage I non-small cell lung cancer (NSCLC) following surgery.

Scientists at the University of Oklahoma have identified a previously unrecognized immune system pathway that helps explain how cigarette smoking increases the risk of cardiovascular disease. The findings, published in Circulation Research, show that cigarette smoke activates immune cells that trigger widespread inflammation throughout the body, accelerating the buildup of plaque in arteries.

An experimental treatment strategy for metastatic pancreatic cancer may help patients live longer by making tumors more visible to the immune system, according to a study published in Nature Medicine. OU Health Stephenson Cancer Center enrolled patients on the clinical trial, which studied a new drug called quemliclustat.